GlassScriptPhysician profile
Xianfeng Wen
NPI 1356669154
$7,069.05
in general payments reported to CMS, 2019-2025
25 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $428 · 2021: $1,091 · 2022: $974 · 2023: $1,230 · 2024: $1,514 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,104.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,384.48 | 2019-2025 | Gallant, Aveir, Jot Dx |
| Impulse Dynamics (USA) INC. | $589.35 | 2022-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $586.86 | 2019-2025 | Watchman Flx, Varithena Administration Pack, Bodyguardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $507.49 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $442.43 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $366.40 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $365.72 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $294.25 | 2019-2022 | |
| Medtronic, INC. | $282.63 | 2021-2025 | Cobalt Dr Mri Surescan, Venaseal, Micra |
| Astrazeneca Pharmaceuticals LP | $168.93 | 2025 | Farxiga, Wainua, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $158.27 | 2019-2023 | Camzyos, Eliquis |
| Amgen INC. | $140.56 | 2019-2022 | |
| Biotronik INC. | $129.61 | 2019-2021 | |
| Medtronic Vascular, INC. | $107.15 | 2020 | |
| Kestra Medical Technology Services, INC. | $101.55 | 2024 | Assure Wcd |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $93.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.65 | 2020-2025 | Jardiance |
| Pfizer INC. | $83.84 | 2019-2025 | |
| Tactile Systems Technology INC | $53.25 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Bard Peripheral Vascular, INC. | $34.98 | 2021 | |
| Esperion Therapeutics, INC. | $21.03 | 2023 | Nexletol |
| Shockwave Medical, INC | $19.76 | 2021 | |
| Irhythm Technologies, INC. | $19.24 | 2022 | |
| Inari Medical, INC. | $17.82 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $13.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xianfeng Wen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.